Skip to main content

Author: Customer Service

Sandisk Corporation to Join the Nasdaq-100 Index® Beginning April 20, 2026

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Sandisk Corporation (Nasdaq: SNDK) will become a component of the Nasdaq-100 Index® (NDX®) replacing Atlassian Corporation (Nasdaq: TEAM) prior to market open on Monday, April 20, 2026. These updates are consistent with the current Nasdaq-100 Index® methodology, in effect through April 30, 2026. For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/ About Nasdaq Global Indexes Nasdaq Global Indexes is one of the world’s leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index® — which measures the performance of 100 of the largest Nasdaq-listed non-financial companies — is tracked by more than 200 investment...

Continue reading

Pilgrim’s Pride Corporation Announces Early Tender Results for up to $250 Million Aggregate Principal Amount of Its Outstanding 6.250% Senior Notes Due 2033

GREELEY, Colorado, April 10, 2026 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) (the “Company”) announced today the early tender results for its cash tender offer (the “Tender Offer”) for up to $250 million aggregate principal amount (the “Maximum Tender Amount”) of its 6.250% Senior Notes due 2033 (the “Notes”). The Company has been advised that as of 5:00 p.m., New York City time, on April 10, 2026 (such date and time, the “Early Tender Date”), $471,546,000 aggregate principal amount of Notes had been validly tendered and not validly withdrawn in the Tender Offer. Withdrawal rights for the Notes expired on the Early Tender Date. The Tender Offer is being made upon the terms, and subject to the conditions, previously described in the offer to purchase dated March 30, 2026 (the “Offer to Purchase”). The Company refers...

Continue reading

AYR Wellness Announces Closing of Exit Facility and Related Transactions

MIAMI, April 10, 2026 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial closing of the transfer of its Virginia operations into Arboretum Virginia LLC, a wholly-owned subsidiary of Arboretum Bidco LLC (“Arboretum”), and the closing and initial funding of its new money exit facility (the “Exit Facility”) with Arboretum, in connection with the Company’s previously announced restructuring transactions (the “Restructuring Transactions”). Arboretum, which intends to operate under the trade name “Ayr Wellness,” is the entity established by the Company’s senior secured noteholders as the designated purchaser under the Master Purchase Agreement, dated November 14, 2025 (the “MPA”). Additional state-level operations...

Continue reading

Brixton Metals Announces Closing of Non-Brokered Private Placement for Gross Proceeds of $4 Million

Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, April 10, 2026 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX- V: BBB, OTCQX: BBBXF) (the “Company” or “Brixton”) is pleased to announce that it has closed a non-brokered private placement offering of 1,110,000 national flow-through shares in the capital of Brixton (“FT Shares”) at a price of $1.35 per FT Share and 1,771,111 critical mineral flow-through shares in the capital of Brixton (the “CMFT Shares”) at a price of $1.44 per CMFT Share, for combined gross proceeds of $4,048,899.84 (the “Offering”). The gross proceeds from the sale of FT Shares will be used to incur “Canadian exploration expenses” and “flow-through mining expenditures” as defined in the Income Tax Act (Canada) (the “Act”). The gross...

Continue reading

UPDATE – QGold to Host Live Webinar to Discuss Corporate Update and PEA

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce that it will be hosting a corporate update presentation with analysts and investors via live webinar on Tuesday, April 14, 2026, at 11:00 a.m. (Toronto time). Participants can register to attend at the following web address: https://us06web.zoom.us/meeting/register/0710C4SnTUWTxff5soUKkg. Specifically, the webinar will feature QGold’s Chief Executive Officer and Executive Chairman, Peter Tagliamonte, to discuss the preliminary results from the Company’s anticipated preliminary economic assessment. About Q-Gold Resources Ltd. Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) is a publicly traded North American-based mineral exploration and development...

Continue reading

Consolidated Lithium Metals Announces Closing of $8.9 Million Private Placement Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) is pleased to announce that, further to its press release on March 18, 2026, it has closed the second and final tranche (the “Final Tranche”) of its previously announced non-brokered offering (the “Offering”) of securities of the Company. Together with the first tranche of the Offering, the Company obtained gross proceeds of approximately $8,935,320. In connection with the Final Tranche, the Company obtained aggregate gross proceeds of approximately $1,050,320 by issuing 10,940,830 flow-through shares of the Company (each, a “Critical FT Share”) at a price of $0.096 per Critical FT Share. Each Critical...

Continue reading

Tenaris Convenes the Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders

LUXEMBOURG, April 10, 2026 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced today that has convened its Annual General Meeting of Shareholders to be held on May 12, 2026, at 10:00 (Central European time), and an Extraordinary General Meeting of Shareholders to be held immediately after the adjournment of the Annual General Meeting of Shareholders. The convening notice (which includes the agendas for the meetings and the procedure for attending and/or voting at the meetings) was published in such newspapers and filed with the regulators, as required by applicable law, and is available on the Luxembourg Stock Exchange’s website at www.bourse.lu/regulated-information-oam, the SEC’s website at www.sec.gov, and Tenaris’s website at ir.tenaris.com. The following documents are also available on Tenaris’s...

Continue reading

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Company’s Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma. Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced cancer patients. In the IGNYTE trial, patients with confirmed progression on an anti-PD-1 based regimen who received RP1 plus nivolumab had a 34% response rate with a median duration of 24.8 months...

Continue reading

Lithium Ionic Provides Update

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is is aware of the Ontario Securities Commission’s publication regarding a regulatory matter involving another reporting issuer and individuals who have, or have had, an association with the Company. Lithium Ionic is not a respondent in this matter and no orders have been sought against Lithium Ionic. The allegations contained in the proceeding have not been proven. The Board of Directors has established a Special Committee of independent directors to oversee the Company’s communications and disclosure in respect of this matter. About Lithium Ionic Corp. Lithium Ionic is a Canadian lithium development company focused on responsibly advancing its 100%-owned Bandeira Lithium...

Continue reading

Pelthos Therapeutics Announces CFO Transition

Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer DURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced John M. Gay has been appointed Chief Financial Officer effective April 10, 2026. Mr. Gay succeeds Francis Knuettel II, who served as Pelthos’ Chief Financial Officer since July 2025. “John played a key role in helping us establish and launch Pelthos. He is an experienced financial leader, and we are excited to have him step into this new role as we continue our strong commercial momentum and enter the next phase of the company’s growth,” said Scott Plesha, CEO of Pelthos. “We also want to thank Frank...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.